Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

GM Plants To Grow Vaccines Against Killer Diseases

18.03.2005


Genetically modified (GM) plants are to be used to grow vaccines for use in the worldwide fight against HIV, tuberculosis, diabetes and rabies thanks to a grant of 12 million euros from the EU’s Sixth Framework Programme (FP6).



‘Pharma-Planta’ draws on the expertise and experience of 39 scientists from 11 European countries and South Africa to address significant health problems affecting Europe and the developing world - although the primary aim is to provide medicines for poorer countries.

In the first international project of its kind, ‘Pharma-Planta’ will develop the concept from plant modification through to clinical trials and they expect to begin human trials of the drugs within four years.


“We are addressing the serious issue of global inequality of health”, says scientific coordinator, Professor Julian Ma from St George’s Hospital Medical School in London. “Although the major burden of 21st century disease is in the developing world we have to accept it as a global problem as these are the countries that do not have access to vaccines.

“We know we can use GM technology to force a plant’s molecular apparatus to produce a range of medically useful compounds. Already genetic modification of other organisms is being used to produce human insulin and a hepatitis B vaccine. However, plant derived materials used in humans have never been formally addressed within the EU. So, this is a ground-breaking project that aims to provide help for the millions of people that die each year throughout the world from vaccine preventable diseases.”

Because plants are inexpensive to grow they could be used to produce large quantities of drugs or vaccines at low cost - anywhere between 10 and 100 times lower than conventional production, which is often labour intensive, expensive and often produces relatively small amounts of pharmaceuticals.

If the project is successful, the techniques would be licensed to developing countries. They would then be able to start up their own production to generate whatever amount they require at a cost that would not impact greatly on the countries economy.

Although the project has not finally decided which plants will be used, the likely candidates are tobacco or maize.

“The ‘Pharma-Planta’ project is an excellent example of how EU Framework Funding is being used to help research and development projects that will have a major impact on the everyday lives of people both in Europe and around the world”, says Claire Horton FP6UK’s National Contact Point for ’Life sciences, genomics and biotechnology for health. “This funding helps bring together experts from different countries to work together in the fight against diseases that can affect us all.

“The current Framework Programme (FP6) runs until 2006 and organisations wanting free information on how to access some of the 19 billion euros available should log on to http://fp6uk.ost.gov.uk or call central telephone support on 0870 600 6080.”

Dave Sanders | alfa
Further information:
http://fp6uk.ost.gov.uk

More articles from Agricultural and Forestry Science:

nachricht Plasma-zapping process could yield trans fat-free soybean oil product
02.12.2016 | Purdue University

nachricht New findings about the deformed wing virus, a major factor in honey bee colony mortality
11.11.2016 | Veterinärmedizinische Universität Wien

All articles from Agricultural and Forestry Science >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Electron highway inside crystal

Physicists of the University of Würzburg have made an astonishing discovery in a specific type of topological insulators. The effect is due to the structure of the materials used. The researchers have now published their work in the journal Science.

Topological insulators are currently the hot topic in physics according to the newspaper Neue Zürcher Zeitung. Only a few weeks ago, their importance was...

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Researchers identify potentially druggable mutant p53 proteins that promote cancer growth

09.12.2016 | Life Sciences

Scientists produce a new roadmap for guiding development & conservation in the Amazon

09.12.2016 | Ecology, The Environment and Conservation

Satellites, airport visibility readings shed light on troops' exposure to air pollution

09.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>